Page last updated: 2024-12-06
4-bromo-2-chlorophenol
Cross-References
ID Source | ID |
PubMed CID | 19859 |
CHEBI ID | 38852 |
SCHEMBL ID | 75671 |
MeSH ID | M0202690 |
Synonyms (34)
Synonym |
AN-329/41610044 |
inchi=1/c6h4brclo/c7-4-1-2-6(9)5(8)3-4/h1-3,9 |
4-bromo-2-chlorophenol , |
phenol, 4-bromo-2-chloro- |
4-bromo-2-chlorophenol, 99% |
2-chloro-4-bromophenol |
3964-56-5 |
CHEBI:38852 |
STK062696 |
B1819 , |
AKOS000120267 |
A824669 |
4-bromo-2-chloro-phenol |
phenol, 4-bromochloro- |
einecs 223-572-5 |
994sj34d8p , |
unii-994sj34d8p |
FT-0617760 |
AM20050313 |
AB00210 |
SCHEMBL75671 |
4-bromo-chlorophenol |
1-bromo-3-chloro-4-hydroxybenzene |
F3145-2417 |
W-106414 |
PS-8062 |
AC-26232 |
CS-W007527 |
DTXSID30192745 |
mfcd00002166 |
Z57233584 |
phenol, 4-bromo-2-chloro-; 4-bromo-2-chlorophenol; 2-chloro-4-bromophenol |
Q27117997 |
EN300-18158 |
Drug Classes (3)
Class | Description |
halophenol | |
monochlorobenzenes | Any member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine. |
organobromine compound | A compound containing at least one carbon-bromine bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 39.39
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 39.39 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 49.55 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |